Showing results (181-190 of 246) with videos related to
Sort By:
Pageof 25
Clinical Genetics|July 2, 2021
The first two non-Finnish HYLS1 variants: Expanding the phenotypic spectrum of hydrolethalus syndromeLeïla Ghesh, Marie Denis Musquer, Louise Devisme, et al.Plos Genetics|December 16, 2024
A Taybi-Linder syndrome-related RTTN variant impedes neural rosette formation in human cortical organoidsJustine Guguin, Ting-Yu Chen, Silvestre Cuinat, et al.Bioorganic & Medicinal Chemistry Letters|March 26, 2023
Synthesis and SAR of a novel Kir6.2/SUR1 channel opener scaffold identified by HTSCayden J Dodd, Keagan S Chronister, Upendra Rathnayake, et al.Journal of Medical Genetics|October 4, 2005
Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's diseaseE R Martin, P G Bronson, Y-J Li, et al.Journal of Molecular and Cellular Cardiology|December 3, 2014
Reactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cellsTatiana N Sidorova, Liudmila V Yermalitskaya, Lisa C Mace, et al.Nature Communications|August 16, 2020
Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- miceHuan Tao, Jiansheng Huang, Patricia G Yancey, et al.ACS Chemical Neuroscience|February 21, 2025
Discovery of ONO-2920632 (VU6011887): A Highly Selective and CNS Penetrant TREK-2 (TWIK-Related K+ Channel 2) Preferring Activator In Vivo Tool CompoundKentaro Yashiro, Yuzo Iwaki, Hirohito Urata, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|December 15, 2015
Clinical, genetic and neuropathological findings in a series of 138 fetuses with a corpus callosum malformationCaroline Alby, Valérie Malan, Lucile Boutaud, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 25, 2016
Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma MetastasisOlivier Boutaud, I Romina Sosa, Taneem Amin, et al.BMC Pharmacology & Toxicology|January 8, 2020
Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trialLisa M Pitchford, Patricia M Driver, John C Fuller, et al.Pageof 25